In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering: Addressing the Specialist Challenge

Executive Summary

As a large yet specialist firm, Schering must compete in multiple areas. That means developing and marketing differentiated products across a number of fronts--and dealing with the lower-than-average margins that typically come with mixed portfolios. How well the German group overcomes these challenges should be of growing interest to Big Pharma, given the risks of relying on blockbusters.
Advertisement

Related Content

Merck KGAA's Hostile Bid Catalyzes Bayer-Schering Combo
Intendis: Mid-Sized Specialist Spawns Small Specialist
The Anti-Global, Specialist Strategy: Why Bayer's Choice Might Be Right for Other Pharmas
Serono Deals Its Way Into Oncology
The Vioxx Withdrawal: Can the Industry Avoid the Whirlpool?
Antegren: Shaking Up the MS Market?
In Pursuit of Primary Care, Schering-Plough Is Growing against the Grain
Schering: Building Franchises
Schering: Building Franchises
Drug Franchises

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002243

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel